Speakers:
William Archey
Alliance & Ecosystem Management Leader
F. Hoffmann - La Roche Diagnostics Partnering
William has 20 years experience and is a leader for pharma, diagnostics, and clinical decision insight. He is trained (PhD, MBA) as an engineer, and in molecular oncology – with a demonstrated global and affiliate record in (1) orchestrating complex, integrated (pharmaceutical + diagnostic) healthcare solution partnerships in precision medicine (data & insight exchanges).
Dr. Evangelos Avramakis
Lead Corporate Foresight, Intelligence & Development
Swiss Re
Evangelos Avramakis is a recognised thought leader and advisor in insurance industry and works for the Swiss Re Institute. He is a design thinker and a holistic, interdisciplinary, and implementation-oriented strategist and doer. Thus, among other tasks he liaises strongly with academia, insurtech, medtech, and start-up ecosystem. His main focus covers digital and consumer related topics such as digital ecosystems, omni channel management, and business model innovation. He has worked in the life and health primary insurance industry in various senior managing and steering positions such as marketing & sales, business development, and market strategy.
Rob Barber, CA-AM
Senior Director Alliance Management
VaxEquity
Rob is a proactive alliance management professional and project leader in all phases of the pharmaceutical lifecycle. Before his current role at VaxEquity, he worked as director alliance management at Mundipharma. He is an expert in issue resolution, brokering novel and collaborative solutions for the benefit of all parties.
Emma Barton
Director, Alliance and Integration Management
AstraZeneca
Emma is a Business Development professional with over fifteen years of industry experience and a track record of successful transactions and post-deal management. Broad business development experience spanning search and evaluation, transactions and strategic alliance management. Current specific focus on deal value delivery from M&A and divestment activities to ensure efficient asset & business transfer across US, EU and International markets.
Nicolas Becker, CA-AM
Director Business Development & Licensing, Alliance Management
Bayer
Nicolas has 22 years of experience in Pharmaceutical & OTC industry. He has a passion for Business Development & Licensing and Alliance Management. He is skilled at negotiating, executing and managing alliances from mid/late-stage R&D to commercial partnerships and M&A transactions.
Jan Beger
Senior Director Digital Ecosystem EMEA
GE Healthcare
As Senior Director of the Digital Ecosystem, Jan's role is to drive GE Healthcare Digital Europe's Ecosystem Strategy and together with his team develop cooperation with partner companies, indirect channels, start-up centers and networks. Jan is the head of GE Healthcare's EdisonTM Accelerator.
With over 15 years of experience in healthcare informatics, the medical imaging domain and management, Jan is a seasoned leader with vast experience in leading strategic initiatives and influencing strategic decisions that ultimately drive revenue and contribute to enterprise value.
Prior to joining GE Healthcare, Jan has held consultancy roles in Digital Health start-ups and Radiology IT companies. Prior to his Digital Ecosystem responsibility at GE Healthcare, he has been responsible for leading clinical consultancy at GE Healthcare Digital in Europe, Middle East & Africa where he and his team ensured and optimized the quality of clinical solution architecture, clinical workflow consultancy, change management and user adoption.
Jonathon Bell
Director, Alliance and Integration Management
AstraZeneca
Jonathon is a Senior Business Development professional with significant experience in Due Diligence, Alliance Management and Opportunity Evaluations and more than 20 years experience in the Pharmaceutical Industry. At AstraZeneca, he works as Director, Alliance and Integration Management; earlier he was Due Diligence Director. Prior to this, he worked at GSK as Commercial Director, Emerging Markets R&D and Director, Commercial Analysis. In additional he has held commercial, licensing and other roles in global companies during his career.
Elena Cavalli, CSAP
Head of Commercial Alliances
Astellas
Elena Cavalli is an experienced Pharma Professional with strong Alliance Management and Divestment capabilities. With a highly flexible mindset, she has held a variety of positions, global, affiliate and regional primarily at Hoffmann La Roche and for the past 17 years at Astellas Pharma Europe. Since having established the Alliance Management function within Astellas EMEA, Elena has generated the culture of thorough internal alignment for core partnerships ahead of every key discussion with the partners. This has created an effective professional partnership environment, very well received by upper management and partners. Elena is an enthusiastic active ASAP member; CA-AM and CSAP certified.
Liam Cleaver
Research Director
IBM Institute for Business Value
Liam is Research Director for the IBM Institute for Business Value (IBV) focused on ecosystem and industry partnerships. For over 20 years Liam has led C-level enterprise transformation programs on a massive scale internally and with our client CxOs to tap into the collective wisdom of the company, industry, or ecosystem accelerating change, driving innovation, and increasing alignment to strategic direction.
Nicole Colwell
Executive Vice President, Chief Alliance Officer
PraSaga Foundation
Nicole Colwell is an accomplished tech industry leader with over 25 years in the industry, making her mark at influential organizations like GE, Hewlett Packard, and Avaya. Currently as EVP/Chief Alliance Officer at the PraSaga Foundation, she champions collaborative alliances to drive tech innovation. Recognized among the top women in Web3, Nicole is also founder of WESAGA, empowering women in emerging technology. Nicole's insights have graced global stages, including the United Nations, spotlighting her expertise in shaping technology's future through strategic alliances.
Henri Dekker
Professor
Vrije Universiteit Amsterdam
Henri Dekker is Professor of Management Control at the School of Business and Economics at Vrije Universiteit Amsterdam, and is head of the department of Accounting. Henri's research primarily focuses on governance, performance management, and control within and between organizations. His work has been published in a variety of accounting and management journals and has been recognized by several awards. He also plays an active role on the editorial boards of a range of accounting journals. Henri teaches in various courses on management accounting and control at the undergraduate, graduate, and executive level.
Ard-Pieter de Man, CSAP, PhD
Professor
Vrije Universiteit Amsterdam
Ard-Pieter de Man PhD is a board room consultant and professor of Management Studies at the Vrije Universiteit Amsterdam. He is an internationally recognized thought leader in the areas of organizational forms, ecosystems, platforms, and alliances. As a consultant he advises organizations on these issues on a strategic level. He is the author of over a hundred articles and fifteen books: How to survive the organizational revolution, that helps managers make sense of new organizational forms, and the widely used Alliances: An executive guide to designing successful strategic partnership.
Annick De Swaef, CSAP
CEO
Belgian Road Research Center
Annick De Swaef is CEO of Belgian Road Research Center. She joined BRRC in 2017, bringing more than 20 years of management experience in the public sector and consulting industry.
Previously, De Swaef founded Consensa Consulting in 2009, a Belgian based company specialized in strategic partnerships and alliances. Prior to that, she spent 7 years at the Public Administration of the Brussels Capital region, where she held a variety of management roles from leading a team of road contract managers to implementing organizational change programs.
Annick De Swaef graduated from Ghent University in 1995, earning her master's degree in construction engineering. She is passionate about guiding organizations on their journey to build and operate successful long term business collaborations. She's been an active member of ASAP and a strong advocate for the added value of the ASAP community and best practices for business leaders.
Nina Detzen
Assistant Professor
Vrije Universiteit Amsterdam
Nina Detzen is an Assistant Professor of Management Accounting at the School of Business and Economics at Vrije Universiteit Amsterdam. Her research focuses on the study of human behaviour in the context of (management) accounting. She is particularly interested in psychological theories that help understand the complex influences of management control systems and job environments on individuals in the (management) accounting profession. Nina teaches courses on management accounting and data analytics as well as a portfolio course at the undergraduate and graduate level.
Fiona Ducotterd, CSAP, PhD
Chief Scientific Officer
Alzheimer's Research UK
Professor Fiona Ducotterd, CSAP, PhD is Chief Scientific Officer at the Alzheimer’s Research UK Drug Discovery Institute at University College London (UCL). Fiona is a trained neuroscientist and drug discovery executive with experience spanning research and development, business development and strategic alliances in pharma (e.g. MSD, GSK, Eisai), biotech (e.g. Vertex, Mindset, Shackelford) and academia (UCL) in the UK, Japan, China and the USA. At UCL, she leads a team of multidisciplinary scientists discovering new medicines for neurodegenerative diseases in partnerships with leading academic innovators as well as industry alliances and spin out companies.
Fiona has a BSc in Molecular Biology from the University of Edinburgh and a PhD in Neuroscience from the University of Newcastle upon Tyne in the UK and is a Certified Strategic Alliance Professional (CSAP).
Fiona is a mentor and coach to early career professionals, particularly those that are under-represented in the industry and a mum to 2 year-old daughter, Isla and fur baby, Yuna.
Laurence Dugue
Head of Alliances & Partners
Sage
Laurence started her career as direct sales for IBM, then joined Oracle's in the Strategic Alliances' team where she developed her indirect sales skills. After Ariba to manage their most significant partners at European level, Laurence spent 3 years at SAP as Partners Director for France and North Africa. End 2004, she left SAP to co-found A2Partner, Consulting firm leader in Partnerships for B2B to join GENERIX Group, VP for Alliances & Channel International, building a new Partnership' Direction for all types of Partners, in coordination with all Generix' Subsidiaries and to open new countries. Now at Sage, Head of Alliances & Partners for Large Enterprise, managing Value Added Resellers, Consulting firms, System Integrators and Software Vendors. Founder and President of ADALEC, French National Association for Partners' Managers, and teaching since 8 years, Master 2 students in Indirect Sales at Montpellier Management.
Ameriga Fanigliulo, CA-AM, PhD
Director, Alliance Management
Sandoz
Ameriga is a Certified Alliance Management Professional (CA-AM) with 15+ year experience in Pharma R&D, Operations, and alliances. Since 2020, she is an Alliance Management Director at Sandoz Biopharma, leading global alliances for biosimilars from development phase to the patients. With her strategic focus she ensures that the partnerships stay aligned with the envisioned purpose and, when needed, she has restructured several strategic alliances to better deliver the expected deal value. Ameriga started her career at the GSK R&D center in Verona as a scientist, but then developed an interest in business and collaborations and moved to the outsourcing business. When she joined Gilead in 2015 she could leverage both her technical background as PhD in chemistry and her business acumen (MBA) to form and lead the European Strategic Outsourcing team for Analytical Operations.
Dr. Sabine Greulich
Senior Vice President Alliance Management
Boehringer Ingelheim
Dr. Sabine Greulich is SVP Alliance Management Human Pharma at Boehringer Ingelheim. She was previously the Country Managing Director Italy, Head Human Pharma Italy and had other leadership roles at Boehringer including the Head of the Business Unit Speciality Care. Prior to her current company, she also servced at Fresenius Biotech (as VP, Head Oncology Europe) and at Eli Lilly (as BU Head Oncology).
Michael Hill-King
Collaboration Director
Huawei
Michael is an innovation & technology leader with a broad background. His strengths are in alliances, programme management, technology transfer and innovation strategy. Professionally, he delivers business - academic relations in an international context, working with the most research-intensive universities in the UK. At Huawei, he is responsible for all strategic engagement with scientific, technology and engineering partners in the UK. He leads the team that builds partner relationships, drives technology planning, scouts for great technology, identifies acquisition opportunities and manages a broad portfolio of technology cooperation and innovation projects.
Sebastiaan Hobs
Head of Business Development
Swiss Re
Sebastiaan is an experienced leader in the reinsurance sector with proven execution skills. He is currently Head of Business development at Swiss Re Corporate Solutions. He was previously Head of Group COO Executive Office at Swiss Re.
Flavio Jose
Strategic Alliances Manager
Varian, a Siemens Healthineers Company
Flavio Jose is an Strategic Alliances Manager at Varian, a Siemens Healthineers Company. Flavio is a Medical Physicist and has also a MSc in Business Administration and an MBA in Marketing. After three years as a researcher in dosimetry and some clinical experience, he changed his career path to technology management. He researched partnerships in pharma using Intellectual Property (IP) metrics, and then advanced his research on innovation of medical devices. In 2014 he was invited to pursue a PhD in Engineering in South Korea and moved to the peninsula, working as a researcher and ad hoc in other industries (e.g. cinema) for about four years. In 2018 Flavio relocated to England, working as a Technical Development Manager at then Public Health England (currently UK Health Security Agency), Business Manager at the Royal Surrey NHS Foundation Trust, and Business Development Manager at the University College London. In early 2022 he crossed the Channel to start his current role at Varian, based in central Switzerland. Flavio's umbrella covers alliances in radiotherapy-related areas such as Quality Assurance (QA), Treatment Planning and Management System (TPMS), Artificial Intelligence (AI), and others.
Markus Kropf
Vice President, Head of Global Alliance Management
Merck KGaA
Romuald Laine, CA-AM, PhD
Head of Alliance Management
Servier
Romuald has significant experience as an alliance executive, but in his current role as Head of Alliance Management at Servier and his previous role as VP Strategic Alliances at Ipsen. Additionally, he served as a global project leader for leading pharma companies with a variety of strategies that were implemented. He was also a Post Doctoral Fellow at the University of California and received his doctorate at Pierre and Marie Curie University.
Julie Little, CSAP
Associate Director, Strategic Alliances
Cancer Research Horizons
Julie is Associate Director Strategic Alliances, leading Cancer Research Horizon's team that manages a portfolio of long-term, strategic alliances with one or more external partners in Europe, US and Japan, to translate novel academic research based on shared values and common goals to address a cancer challenge. The team supports building of new alliances and are also responsible for business intelligence, data analysis and post-deal administration. She also played key roles in establishing alliances with Merck Healthcare KGaA, AstraZeneca, and Abcam. Cancer Research Horizons is the commercial arm of Cancer Research UK. Julie joined Cancer Research Horizons in 2012 transitioning into business development, after a career of nearly 25 years in discovery research, predominantly involving antibody technology, at Unilever plc and Genzyme.
Alessandro Maloberti
Senior Director Partner Ecosystem
STMicroelectronics
Alessandro is leading the companywide Partner Ecosystem Program since 2015, he is currently based in Geneva, Switzerland.
His current in charge of for the definition and development of the technical, marketing and business relationships between STMicroelectronics and more than three hundred partners. These Partners provide complementary products and services to support customers in the usage of company's devices in the development of their final products.
During his international career in the semiconductor industry, he has covered positions in R&D, Technology Development, Marketing, Digital Marketing, Market Development and even Corporate Communication. Alessandro holds a Master's degree in electronics with major in semiconductor and an executive master's in technology management.
Mikel Mangold
Startup Ecosystem - Alliances & Partnerships
Venture Lab, Niterra Group
Mikel is an Innovation PM at Venture Lab; ecosystem orchestrator and author.
He is a Chemist by training, entrepreneurial in nature, with international experience in open innovation: digital health, pharma, energy, cleantech & mobility. He has recognized expertise in bringing eclectic stakeholders and enabling constructive collaboration to a shared outcome. He previously worked for Bayer G4A (Digital Health Start-Up Accelerator) and the Bayer CoLaborator (Biotech Start-Up Incubator) in San Francisco.
He is a Published Author of Today's Superpower: Building Networks and Co-Author of the academic paper: What Corporates Can Do to Help an Innovation Ecosystem Thrive – and Why They Should Do It.
Anthony Marshall
Senior Research Director
IBM Institute for Business Value
Anthony is Senior Research Director for the IBM Institute for Business Value (IBV). He has more than 20 years of consulting, research, and analytical experience. He has consulted extensively with US and global banks, working with numerous top-tier organizations in innovation management, digital strategy, transformation, and organizational culture. He leads a global team of 60 research leaders, analysts and econometricians.
Martijn Maters
Global Alliances and Strategic Initiatives Leader
ZF Group
Martijn's career spans over 12 years including strategy, business development and partnerships, marketing, global sales and innovation roles. His current role is in the digital team of ZF's Commercial Vehicles division. He is responsible for the digital alliances and eco system strategy for the Commercial Vehicle division. Overall, his goal is to drive long term business growth globally, through impactful strategic partnerships, M&A and the (co-) creation of innovative industry solutions.
George Rahim, PhD
Former Vice President of Strategic Alliances
Ipsen
George entered the field of alliance management as the first global alliance director at Roche following a 15-year career in medicinal chemistry at Wellcome and GlaxoWellcome and biotech consulting. After a 9-year career at Roche in UK and Switzerland in alliance management, BD and M&A integrations he joined GSK Biologicals in Belgium to establish and head a new alliance management and operations function managing a range of strategic alliances in vaccines development.
In 2015 George joined UCB in Brussels where he developed a centre of expertise and a community in alliance management creating a recognized and value-adding capability within the company for managing external partnerships. George joined Ipsen in 2019 as VP head of strategic alliances Europe where he also developed the alliance management centre of excellence which has been instrumental in training the company’s alliance managers. George holds a PhD in Chemistry from the University of Birmingham, UK.
Kevin Schneebeli
Senior Expert Partnerships & Eco Systems
Generali
Kevin is a value-network & Ecosystem expert, a practitionor of sustainable FinTech and a lecturer. After completing his commercial training, Kevin Schneebeli studied business administration at the Kalaidos University of Applied Sciences with a focus on bank management and management and digital transformation. As a result, he acquired an Executive Certificate in Strategy and Innovation from MIT and was able to incorporate his experience in national and international companies. Kevin Schneebeli has over 15 years of experience in the areas of compliance, controlling, M&A and support for start-up companies. Kevin Schneebeli is a course director at the HWZ and also a lecturer in strategy and transformation for the areas of sustainability and technology at various universities of applied sciences in Switzerland.
Ricardo Simard
Head of Strategic Partners, Division X
BT
Over the past 15 years, Richardoh has had the opportunity to work in diverse industries and countries, taking on various job functions. During this time, his focus has been on developing growth plans, executing go-to-market strategies, building teams and processes, and leading cross-functional teams to achieve success. With a background in consulting and large corporations, he’s passionate about leveraging disruptive technologies to drive innovation and business transformation.
Bo Skaaning Jensen, PhD
Senior Alliance Director, Early Innovation, Outreach and Alliances
Novo Nordisk
Bo Skaaning Jensen is Senior Alliance Director at Novo Nordisk A/S and holds a PhD in Molecular Physiology. Dr. Jensen is a father of two, and enjoys leisure activities such as reading novels, trekking and he is a passionate marathon runner. His career has involved basic science, drug discovery project management, line management, business development, alliance management and several C-suite positions. Since his first position as research scientist at the Danish CNS-focused Company, NeuroSearch, Dr. Jensen has been actively involved in collaborations and partnerships with academia, biotech companies and big pharma. With a track record from small start-ups, listed biotech companies and big pharma, Dr. Jensen has been involved in most aspects of alliance management from the early deal making discussions, via kick-offs and alliance execution to terminations.
Knut Sturmhoefel, CA-AM, PhD
Consultant, Alliance & Collaboration Advisor
After over 27 years in biotech and big pharma and 17 years at the frontline of business development and alliance management, Knut has seen many success stories as well as failures of collaborations. By sharing his experience and deep insights he enables companies to drive innovation through creating tailored collaborations and executing their alliances with excellence - generating new value for all parties.
At Novartis, Knut served as vice president, global head of alliance management where he strengthened the corporate alliance management function across five divisions, managing a team of seasoned alliance leaders who were responsible for a portfolio of over 300 alliances. Previously, he served as global head of BD&L for two franchises, ophthalmology and respiratory. Knut's teams were responsible for all business development activities, in- and out-licensing, all variations of collaborations, M&A activities and due diligences, and managing the alliance portfolio. In the early years of his 20-year career at Novartis in Switzerland, Knut was leading clinical stage R&D and commercial projects.
Paul Taylor
Vice President, Strategic Partnerships
KONE
Paul Taylor is the global lead for KONE's Strategic Partnerships. Paul and his team define the strategy for KONE's partnership activities, identifying opportunities for joint product development, developing marketing and sales strategies and bringing together resources from multiple companies to ensure successful execution. During his career, Paul has led partnering activities in Siemens, Cisco and AWS, and has lived and worked in both the USA.
Steve Twait, CSAP
President
Integrated Alliance Management
Steve is currently president of a newly formed consulting firm. Steve previously had responsibility for AstraZeneca's global late-phase and commercial alliance and integration management (AIM) strategy and execution capabilities. Steve's team led the integration of asset acquisitions, the transitions for divestments, and management of key late-phase alliances for AZ. Steve joined AZ in January 2015, after spending 26 years at Eli Lilly and Company where he was a founding member of Lilly's Office of Alliance Management. Steve is a well published author in Pharmaceutical Executive, PLG's Business Development & Licensing Journal, and Strategic Alliance Magazine and has been a board member and treasurer of the Association of Strategic Alliance Professionals.
Jan Twombly, CSAP
President
The Rhythm of Business
Jan Twombly, Certified Strategic Alliance Professional (CSAP), is president of The Rhythm of Business, a service provider with core expertise in strategic alliances, alliance management, and collaboration. For more than 20 years, she has been developing and sharing thought leadership to enable success through partnering and alliances.
Twombly is a trusted advisor to leaders in both industry and academia, helping to develop their organizations' partnering and alliance strategies and operations. She offers education, training, and mentoring services to build the mindset, skillset, and toolset needed to succeed. Her clients count on her to advise on establishing new alliances, to develop alliance management organizations and practices, and to step in when alliances are in trouble. Data-driven, contextual assessments of complex alliances provide deep insights that solve problems and drive measurable improvement. Digitizing workflow helps alliance managers scale and optimize their work.
She serves on the Board of Directors of the Association of Strategic Alliance Professionals (ASAP), overseeing their editorial and content strategy. She is a frequent contributor to Strategic Alliance Quarterly, regularly speaks on collaboration and partnering, and authors The Partnering Guide blog and numerous whitepapers at www.rhythmofbusiness.com.
Markus Wabnegg
Assistant Professor
WU Vienna and University of Krems
Markus Wabnegg is an Assistant Professor of Management Accounting at WU Vienna and the University of Krems. In his research, he is particularly interested in understanding the role of performance measures, incentives, and target setting for guiding R&D-employees' behavior – both within firms and across organizational boundaries. Markus also regularly teaches courses on management accounting, data analytics, and strategic management on an undergraduate, graduate, and executive level.
Jennifer Watt
Senior Vice President, Head of Global Alliances
Vir Biotechnology
Jennifer is leading global alliances at Vir Biotechnology, where she is working on a variety or projects that she will explore in her presentation.
She was previously Executive Director for Global Alliances at Gilead Sciences, where she led global alliances to develop and commercialize novel infectious disease therapies in HIV and Ebola. And she was a core member of the BD deal teams for multiple strategic transactions.
Christian Wolf
Head of Strategic Partnerships & Ecosystems
Raiffeisen Bank International
Christian Wolf, as Head of Strategic Partnerships & Ecosystems in Raiffeisen Bank International AG (RBI), works on cross-industry co-innovation initiatives with a focus on strategic business model and market innovation. In this role, he and his team develop and run RBI's Elevator Lab, CEE's largest award-winning fintech partnership program. Beyond that, he takes responsibility for positioning RBI as a valuable ecosystem partner in cooperation with Corporates, BigTechs and FinTechs alike. Further, he and his team assume direct implementation responsibility for RBI's Open Banking strategy and new business model development based on disruptive technologies such as e.g. Blockchain.